{"pub": "reuters", "url": "https://reuters.com/article/us-takeda-pharma-divestiture/takeda-sells-mideast-africa-drugs-to-switzerlands-acino-for-around-200-million-idUSKBN1WU0TZ", "downloaded_at": "2019-10-15 08:11:35.754112+00:00", "title": "Takeda sells Mideast, Africa drugs to Switzerland's Acino for around $200 million", "language": "en", "text": "FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File Photo\n\nTOKYO (Reuters) - Japan\u2019s Takeda Pharmaceutical Co Ltd (4502.T) said on Tuesday it will sell a portfolio of over-the-counter (OTC) and prescription medicines in the Middle East and Africa to Swiss pharmaceuticals company Acino for more than $200 million.\n\nThe sale, which Takeda said in a statement is expected to close in the quarter ending March, comes as Japan\u2019s biggest drugmaker looks to trim its debt following the $59 billion purchase of Shire.", "description": "Japan's Takeda Pharmaceutical Co Ltd <4502.T> said on Tuesday it will sell a portfolio of over-the-counter (OTC) and prescription medicines in the Middle East and Africa to Swiss pharmaceuticals company Acino for more than $200 million.", "authors": ["Reuters Editorial", "Min Read"], "top_image": "https://s3.reutersmedia.net/resources/r/?m=02&d=20191015&t=2&i=1441017639&w=1200&r=LYNXMPEF9E0EO", "published_at": "2019-10-15"}